Publicaciones en colaboración con investigadores/as de Hospital Nossa Senhora da Conceição (1)

2021

  1. First-line nivolumab plus ipilimumab combined with two cycles of chemotherapy in patients with non-small-cell lung cancer (CheckMate 9LA): an international, randomised, open-label, phase 3 trial

    The Lancet Oncology, Vol. 22, Núm. 2, pp. 198-211